Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 884

Similar articles for PubMed (Select 17602735)

1.

Preparation and anticoagulation activity of sodium cellulose sulfate.

Wang ZM, Li L, Zheng BS, Normakhamatov N, Guo SY.

Int J Biol Macromol. 2007 Oct 1;41(4):376-82. Epub 2007 May 18.

PMID:
17602735
2.

Anticoagulant property of a semi-synthesized sodium beta-1,4-glucan sulfate.

Wang ZM, Li L, Li B, Guo SY.

Yao Xue Xue Bao. 2006 Apr;41(4):323-7.

PMID:
16856476
3.

Anticoagulant potential of regioselective derivatized cellulose.

Groth T, Wagenknecht W.

Biomaterials. 2001 Oct;22(20):2719-29.

PMID:
11545306
4.

Experimental study on anticoagulant and antiplatelet aggregation activity of a chemically sulfated marine polysaccharide YCP.

Han F, Yao W, Yang X, Liu X, Gao X.

Int J Biol Macromol. 2005 Sep 15;36(4):201-7.

PMID:
16102810
5.

Anticoagulant activity of sulfoalkyl derivatives of curdlan.

Lee KB, Bae JH, Kim JS, Yoo YC, Kim BS, Kwak ST, Kim YS.

Arch Pharm Res. 2001 Apr;24(2):109-13.

PMID:
11339629
6.

Homogeneous sulfation of bagasse cellulose in an ionic liquid and anticoagulation activity.

Wang ZM, Li L, Xiao KJ, Wu JY.

Bioresour Technol. 2009 Feb;100(4):1687-90. doi: 10.1016/j.biortech.2008.09.002. Epub 2008 Oct 29.

PMID:
18973999
7.

Influence of functional groups on the in vitro anticoagulant activity of chitosan sulfate.

Huang R, Du Y, Yang J, Fan L.

Carbohydr Res. 2003 Mar 14;338(6):483-9.

PMID:
12668103
8.

Anticoagulant and antiprotease profiles of a novel natural heparinomimetic mannopentaose phosphate sulfate (PI-88).

Demir M, Iqbal O, Hoppensteadt DA, Piccolo P, Ahmad S, Schultz CL, Linhardt RJ, Fareed J.

Clin Appl Thromb Hemost. 2001 Apr;7(2):131-40.

PMID:
11292191
9.

Evidence for antithrombin III involvement in the anticoagulant activity of cellulose sulphate.

Kindness G, Long WF, Williamson FB.

Br J Pharmacol. 1980 Apr;68(4):645-9.

10.

Relationship between the antithrombotic effect of YM-75466, a novel factor Xa inhibitor, and coagulation parameters in rats.

Sato K, Taniuchi Y, Kawasaki T, Hirayama F, Koshio H, Matsumoto Y.

Eur J Pharmacol. 1998 Apr 24;347(2-3):231-6.

PMID:
9653887
11.

Long duration of anticoagulant activity and protective effects of acharan sulfate in vivo.

Li DW, Lee IS, Sim JS, Toida T, Linhardt RJ, Kim YS.

Thromb Res. 2004;113(1):67-73.

PMID:
15081567
12.

Phosphorothioate oligonucleotides inhibit the intrinsic tenase complex.

Sheehan JP, Lan HC.

Blood. 1998 Sep 1;92(5):1617-25.

13.

Differences in the clinically effective molar concentrations of four direct thrombin inhibitors explain their variable prothrombin time prolongation.

Warkentin TE, Greinacher A, Craven S, Dewar L, Sheppard JA, Ofosu FA.

Thromb Haemost. 2005 Nov;94(5):958-64.

PMID:
16363236
14.

Comparison of established and novel purity tests for the quality control of heparin by means of a set of 177 heparin samples.

Alban S, Lühn S, Schiemann S, Beyer T, Norwig J, Schilling C, Rädler O, Wolf B, Matz M, Baumann K, Holzgrabe U.

Anal Bioanal Chem. 2011 Jan;399(2):605-20. doi: 10.1007/s00216-010-4169-7. Epub 2010 Sep 8. Erratum in: Anal Bioanal Chem. 2011 Jan;399(3):1395.

PMID:
20824424
15.

Anticoagulant and antiprotease effects of a novel heparinlike compound from shrimp (Penaeus brasiliensis) and its neutralization by heparinase I.

Demir M, Iqbal O, Dietrich CP, Hoppensteadt DA, Ahmad S, Daud AN, Fareed J.

Clin Appl Thromb Hemost. 2001 Jan;7(1):44-52.

PMID:
11190904
16.

Fucosylated chondroitin sulfate as a new oral antithrombotic agent.

Fonseca RJ, Mourão PA.

Thromb Haemost. 2006 Dec;96(6):822-9.

PMID:
17139379
17.

Molecular weight and biochemical profile of a chemically modified heparin derivative, Suleparoide.

Callas DD, Ahsan A, Iqbal O, Fareed J.

Thromb Res. 1993 Feb 15;69(4):369-76.

PMID:
8470058
18.

A novel glycosaminoglycan-like polysaccharide from abalone Haliotis discus hannai Ino: purification, structure identification and anticoagulant activity.

Li G, Chen S, Wang Y, Xue Y, Chang Y, Li Z, Wang J, Xue C.

Int J Biol Macromol. 2011 Dec 1;49(5):1160-6. doi: 10.1016/j.ijbiomac.2011.09.017. Epub 2011 Sep 29.

PMID:
21968010
19.

Effects of a synthetic factor Xa inhibitor (JTV-803) on various laboratory tests.

Tobu M, Iqbal O, Hoppensteadt DA, Shultz C, Jeske W, Fareed J.

Clin Appl Thromb Hemost. 2002 Oct;8(4):325-36.

PMID:
12516682
20.

Biomarkers and coagulation tests for assessing the biosimilarity of a generic low-molecular-weight heparin: results of a study in healthy subjects with enoxaparin.

Kuczka K, Harder S, Picard-Willems B, Warnke A, Donath F, Bianchini P, Parma B, Blume H.

J Clin Pharmacol. 2008 Oct;48(10):1189-96. doi: 10.1177/0091270008322911. Epub 2008 Aug 20.

PMID:
18716314
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk